Moody Lynn & Lieberson, LLC Idexx Laboratories Inc Transaction History

Moody Lynn & Lieberson, LLC

$1.48 Billion
Q1 2025

A detailed history of Moody Lynn & Lieberson, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 7,242 shares of IDXX stock, worth $3.81 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,242

Previous 7,242 -0.0%

Holding current value

$3.81 Million

Previous $2.99 Million 1.57%

% of portfolio

0.21%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$406.92 - $495.42 $3,662 - $4,458	9 Added 0.12%	7,242 $2.99 Million
Q1 2024 Apr 23, 2024	BUY	$515.08 - $576.87 $15,452 - $17,306	30 Added 0.42%	7,233 $3.91 Million
Q4 2023 Jan 24, 2024	BUY	$391.37 - $557.56 $2,739 - $3,902	7 Added 0.1%	7,203 $4 Million
Q3 2023 Oct 24, 2023	SELL	$432.42 - $556.67 $5,189 - $6,680	-12 Reduced 0.17%	7,196 $3.15 Million
Q2 2023 Jul 27, 2023	SELL	$450.7 - $503.61 $374,081 - $417,996	-830 Reduced 10.33%	7,208 $3.62 Million
Q1 2023 May 02, 2023	BUY	$406.01 - $514.59 $6,090 - $7,718	15 Added 0.19%	8,038 $4.02 Million
Q4 2022 Feb 01, 2023	SELL	$324.64 - $441.27 $32,788 - $44,568	-101 Reduced 1.24%	8,023 $3.27 Million
Q2 2022 Jul 28, 2022	SELL	$327.37 - $553.44 $88,389 - $149,428	-270 Reduced 3.22%	8,124 $2.85 Million
Q1 2022 Apr 27, 2022	SELL	$466.52 - $631.01 $666,657 - $901,713	-1,429 Reduced 14.55%	8,394 $4.59 Million
Q4 2021 Jan 26, 2022	SELL	$586.54 - $666.48 $4.03 Million - $4.57 Million	-6,863 Reduced 41.13%	9,823 $6.47 Million
Q3 2021 Oct 26, 2021	BUY	$621.9 - $705.76 $2.49 Million - $2.83 Million	4,011 Added 31.64%	16,686 $10.4 Million
Q2 2021 Jul 28, 2021	BUY	$486.36 - $637.08 $1.76 Million - $2.31 Million	3,620 Added 39.98%	12,675 $8.01 Million
Q1 2021 Apr 23, 2021	SELL	$465.18 - $551.79 $363,305 - $430,947	-781 Reduced 7.94%	9,055 $4.43 Million
Q4 2020 Jan 26, 2021	BUY	$383.85 - $499.87 $18,808 - $24,493	49 Added 0.5%	9,836 $4.92 Million
Q3 2020 Oct 28, 2020	SELL	$334.54 - $406.31 $21,745 - $26,410	-65 Reduced 0.66%	9,787 $3.85 Million
Q1 2020 Apr 30, 2020	SELL	$182.94 - $290.97 $15,001 - $23,859	-82 Reduced 0.83%	9,852 $2.39 Million
Q4 2019 Jan 28, 2020	SELL	$248.66 - $285.01 $5.21 Million - $5.97 Million	-20,950 Reduced 67.83%	9,934 $2.59 Million
Q3 2019 Oct 28, 2019	BUY	$260.07 - $289.93 $5.4 Million - $6.01 Million	20,745 Added 204.61%	30,884 $8.4 Million
Q1 2019 Apr 23, 2019	SELL	$178.02 - $225.69 $14,419 - $18,280	-81 Reduced 0.79%	10,139 $2.27 Million
Q4 2018 Jan 29, 2019	SELL	$176.18 - $248.92 $2.74 Million - $3.87 Million	-15,555 Reduced 60.35%	10,220 $1.9 Million
Q3 2018 Oct 29, 2018	SELL	$218.82 - $254.46 $599,785 - $697,474	-2,741 Reduced 9.61%	25,775 $6.44 Million
Q2 2018 Jul 24, 2018	BUY	$185.56 - $227.9 $3.52 Million - $4.32 Million	18,954 Added 198.22%	28,516 $6.22 Million
Q1 2018 Apr 27, 2018	BUY	$157.81 - $204.73 $404,309 - $524,518	2,562 Added 36.6%	9,562 $1.83 Million
Q3 2017 Nov 06, 2017	BUY	$150.32 - $166.46 $1.05 Million - $1.17 Million	7,000	7,000 $1.09 Million

Others Institutions Holding IDXX

# of Institutions

1,260

Shares Held

76.3M

Call Options Held

129K

Put Options Held

219K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $43.8B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Idexx Laboratories Inc Transaction History